Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The American Journal of Psychiatry|December 6, 2017
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical TrialMichael F Grunebaum, Hanga C Galfalvy, Tse-Hwei Choo, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|February 9, 2026
Interrelatedness of Neurocognitive Domain Functioning Between Unprompted and Prompted Identification Testing With Psychophysical Olfactory Evaluation in a Post-COVID-19 CohortJeremy P Tervo, Patricia T Jacobson, Brandon J Vilarello, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|May 26, 2024
Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19Brandon J Vilarello, Patricia T Jacobson, Clayton J Snyder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Journal of Psychiatry and Brain Science|August 29, 2020
Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †Natalie de la Garrigue, Juliana Glasser, Pejman Sehatpour, et al.
Pageof 8